东星医疗
(301290)
| 流通市值：23.13亿 | | | 总市值：29.12亿 |
| 流通股本：7957.85万 | | | 总股本：1.00亿 |
| 利润表 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 营业总收入 | 90,470,397.6 | 387,491,879.48 | 283,737,516.84 | 183,292,306.61 |
| 营业总成本 | 76,752,373.59 | 337,268,334.44 | 245,520,282.82 | 163,130,797.38 |
| 其他经营收益 | | | | |
| 营业利润 | 21,479,282.34 | -26,439,272.63 | -42,533,744.96 | 36,478,950.99 |
| 利润总额 | 21,284,374.25 | -27,577,202.55 | -43,091,173.03 | 35,908,419.49 |
| 净利润 | 17,516,752.96 | -39,895,800.02 | -53,521,791.79 | 29,654,347.94 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | 17,516,752.96 | -39,895,800.02 | -53,521,791.79 | 29,654,347.94 |
| 资产负债表 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 流动资产: | | | | |
| 流动资产合计 | 1,467,981,496.92 | 1,482,954,039.93 | 1,459,214,941.06 | 1,418,914,918.51 |
| 非流动资产: | | | | |
| 非流动资产合计 | 937,108,481.9 | 945,886,988.63 | 940,317,332.02 | 1,046,416,468.6 |
| 资产总计 | 2,405,089,978.82 | 2,428,841,028.56 | 2,399,532,273.08 | 2,465,331,387.11 |
| 流动负债: | | | | |
| 流动负债合计 | 217,802,152.9 | 258,596,257.43 | 241,623,163.49 | 220,762,785.85 |
| 非流动负债: | | | | |
| 非流动负债合计 | 14,966,873.5 | 15,440,571.67 | 16,730,901.9 | 17,737,436 |
| 负债合计 | 232,769,026.4 | 274,036,829.1 | 258,354,065.39 | 238,500,221.85 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 2,165,465,985.88 | 2,147,549,572.8 | 2,132,288,193.82 | 2,218,259,520.12 |
| 股东权益合计 | 2,172,320,952.42 | 2,154,804,199.46 | 2,141,178,207.69 | 2,226,831,165.26 |
| 负债和股东权益合计 | 2,405,089,978.82 | 2,428,841,028.56 | 2,399,532,273.08 | 2,465,331,387.11 |
| 现金流量表 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 88,105,792.21 | 444,035,691.47 | 334,736,503.26 | 221,523,705.58 |
| 经营活动现金流出小计 | 89,010,803.16 | 359,947,105.17 | 286,726,531.02 | 200,137,927.07 |
| 经营活动产生的现金流量净额 | -905,010.95 | 84,088,586.3 | 48,009,972.24 | 21,385,778.51 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 738,712,553.08 | 2,562,498,433.27 | 2,020,494,520.36 | 1,212,079,769.59 |
| 投资活动现金流出小计 | 736,561,357.24 | 2,709,552,154.18 | 2,144,427,364.62 | 1,286,097,187.39 |
| 投资活动产生的现金流量净额 | 2,151,195.84 | -147,053,720.91 | -123,932,844.26 | -74,017,417.8 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 38,141,312.35 | 146,701,872.12 | 113,807,739.85 | 91,185,779.35 |
| 筹资活动现金流出小计 | 42,141,308.37 | 122,593,397.04 | 106,543,369.14 | 92,867,060.96 |
| 筹资活动产生的现金流量净额 | -3,999,996.02 | 24,108,475.08 | 7,264,370.71 | -1,681,281.61 |
| 汇率变动对现金及现金等价物的影响 | -154,544.45 | -511,148.97 | -284,618.09 | -235,469.85 |
| 现金及现金等价物净增加额 | -2,908,355.58 | -39,367,808.5 | -68,943,119.4 | -54,548,390.75 |
| 期末现金及现金等价物余额 | 75,501,592.19 | 78,409,947.77 | 48,834,636.87 | 63,229,365.52 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | -39,367,808.5 | - | -54,548,390.75 |
最新报告期：2026-07-31| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 太平洋 | 李啸岩,谭紫媚 | 1.21 | 2.07 | 2.56 | 2026-07-31 |